Sherwin Navaz
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- S100 Proteins and Annexins 2
- Inflammasome and immune disorders 1
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Yu Zuo (6 shared papers)Jason S. Knight (6 shared papers)Yogendra Kanthi (3 shared papers)Alyssa Harbaugh (3 shared papers)Kelsey Gockman (2 shared papers)Jacqueline A. Madison (3 shared papers)Srilakshmi Yalavarthi (2 shared papers)Claire K. Hoy (3 shared papers)
- Journals
- Arthritis & Rheumatology (2 papers)JAMA Cardiology (1 paper)JCI Insight (1 paper)JAMA Network Open (1 paper)Diagnostics (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Sherwin Navaz
5 papers receiving 144 citations
Peers
Comparison fields: 5 of 38
- Infectious Diseases 56
- Neurology 34
- Immunology 45
- Rheumatology 24
- Obstetrics and Gynecology 8
Countries citing papers authored by Sherwin Navaz
This map shows the geographic impact of Sherwin Navaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherwin Navaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherwin Navaz more than expected).
Fields of papers citing papers by Sherwin Navaz
This network shows the impact of papers produced by Sherwin Navaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherwin Navaz. The network helps show where Sherwin Navaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherwin Navaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2022 | 56 | |
| 3 | 2023 | 17 | |
| 4 | 2022 | 11 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 0 |
About Sherwin Navaz
Sherwin Navaz is a scholar working on Molecular Biology, Infectious Diseases, Rheumatology, Immunology and Organic Chemistry, having authored 6 papers that have together received 146 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), S100 Proteins and Annexins (2 papers), Systemic Lupus Erythematosus Research (2 papers), Inflammasome and immune disorders (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (56 citations), Neurology (34 citations), Immunology (45 citations), Rheumatology (24 citations) and Obstetrics and Gynecology (8 citations). Sherwin Navaz has collaborated with scholars based in United States and China. Frequent co-authors include Yu Zuo, Jason S. Knight, Yogendra Kanthi, Alyssa Harbaugh, Kelsey Gockman, Jacqueline A. Madison, Srilakshmi Yalavarthi, Claire K. Hoy, Melanie Zuo and Hui Shi. Their work appears in journals such as Arthritis & Rheumatology, JAMA Cardiology, JCI Insight, JAMA Network Open and Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.